title: Pemphigus vulgaris in three adolescents: the course of the disease.
abstract: We report three adolescents with pemphigus vulgaris whose disease started at the age of 13, 15 and 14 years, respectively. The course of the disease and the treatment approaches were reviewed. Pemphigus vulgaris during childhood and adolescence is a very rare disease in this part of Europe. Among 410 pemphigus vulgaris patients that we treated during the 20-year period, only three patients (0.73%) were under the age of 18 years. According to our experience, the course of pemphigus vulgaris in patients before the age of 18 years is comparable with the course of pemphigus vulgaris in adults.
authors.affiliation: Clinic of Dermatovenereology, Clinical Center of Serbia and Faculty of Medicine, University of Belgrade, Belgrade, Serbia. limed@eunet.rs
authors.forename: Svetlana
authors.initials: S
authors.lastname: Popadic
authors.forename: Ljiljana
authors.initials: L
authors.lastname: Medenica
authors.forename: Dusan
authors.initials: D
authors.lastname: Skiljevic
authors.forename: Zorana
authors.initials: Z
authors.lastname: Djakovic
authors.forename: Milos
authors.initials: M
authors.lastname: Nikolic
mesh_terms: D000293:Adolescent; D001379:Azathioprine / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010392:Pemphigus / Q000175:diagnosis* / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis
chemical_list: D005938:Glucocorticoids; D003907:Dexamethasone; D003622:Dapsone; D001379:Azathioprine; D011241:Prednisone